Search

Your search keyword '"Samer S. Najjar"' showing total 266 results

Search Constraints

Start Over You searched for: Author "Samer S. Najjar" Remove constraint Author: "Samer S. Najjar"
266 results on '"Samer S. Najjar"'

Search Results

1. From Hip to Heart: A Comprehensive Evaluation of an Infiltrative CardiomyopathyNovel Teaching Points

2. Left Ventricular Assist Devices: A Primer For the General Cardiologist

Catalog

Books, media, physical & digital resources

3. Bridge to nowhere: A retrospective single-center study on patients using chronic intravenous inotropic support as bridge therapy who do not receive surgical therapy

4. Intra‐Aortic Balloon Pump as a Bridge to Durable Left Ventricular Assist Device

5. Rare Case of Coincident Quadricuspid Pulmonic Valve and Suprapulmonic Ridge

7. Higher levels of allograft injury in black patients early after heart transplantation

8. Incidence and Outcomes of Gastrointestinal Bleeding in Patients With Percutaneous Mechanical Circulatory Support Devices

9. From Hip to Heart: A Comprehensive Evaluation of an Infiltrative Cardiomyopathy

10. Outcomes in patients with smaller body surface area after HeartMate 3 left ventricular assist device implantation

11. Chronic Intravenous Inotropic Support as Palliative Therapy and Bridge Therapy for Patients With Advanced Heart Failure: A Single-Center Experience

12. VE/VCO2 slope predicts RV dysfunction and mortality after left ventricular assist device: a fresh look at cardiopulmonary stress testing for prognostication

13. Longitudinal uncoupling of the heart and arteries with aging in a community-dwelling population

14. Temporal Associations and Outcomes of Breast Cancer and Heart Failure in Postmenopausal Women

15. Sex-Associated Differences in Cardiac Reverse Remodeling in Patients Supported by Contemporary Left Ventricular Assist Devices

16. Outcomes of Severely Obese Patients Supported by a Centrifugal-Flow Left Ventricular Assist Device

19. Benefits and Harms of Continuous Intravenous Inotropic Support as Palliative Therapy: A Single-Institution, Retrospective Analysis

20. Circulating microRNAs in cellular and antibody-mediated heart transplant rejection

21. Response by Shah et al to Letter Regarding Article, 'Cell-Free DNA to Detect Heart Allograft Acute Rejection'

22. Beta-blockers and Ambulatory Inotropic Therapy

23. Rare Case of Coincident Quadricuspid Pulmonic Valve and Suprapulmonic Ridge

24. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial

25. The impact of left ventricular size on outcomes after centrifugal-flow left ventricular assist device implantation

26. Intra‐Aortic Balloon Pump as a Bridge to Durable Left Ventricular Assist Device

27. Coronavirus Disease 2019 in Heart Transplant Recipients: Risk Factors, Immunosuppression, and Outcomes

28. Characteristics and Outcomes of Patients with Inflammatory Cardiomyopathies Receiving Mechanical Circulatory Support: An STS-INTERMACS Registry Analysis

29. The Impact of Adverse Events on Functional Capacity and Quality of Life After HeartWare Ventricular Assist Device Implantation

30. CELL-FREE DNA TO DETECT HEART ALLOGRAFT ACUTE REJECTION

31. Abstract 14887: Look Beyond the Coronaries: A Rare Cause of Acute Papillary Muscle Rupture

32. VE/VCO2 slope predicts RV dysfunction and mortality after left ventricular assist device: a fresh look at cardiopulmonary stress testing for prognostication

33. General surgery in patients with left ventricular assist devices: Do not cross the line!

34. Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: An analysis from the MOMENTUM 3 study

36. Neurologic Events in Continuous-Flow Left Ventricular Assist Devices

37. Edge‐to‐edge mitral repair for iatrogenic chordal rupture related to Impella 5.0

38. A Hemolytic Event in a Heartmate 3 Patient in the Setting of Polycythemia

39. Effect of Radiation in Patients with HeartMate 3 LVAD Therapy

40. Impact of Using a Low Anti-Xa Target Heparin Protocol on Hemocompatibility-Related Outcomes after Implantation of a HeartMate 3 Device

41. The Effect of Body Mass Index on Presentation of COVID-19 amongst Heart Transplant Recipients: A Multi-Institutional Study

42. Adverse Event Rates Change Favorably Over Time for Patients Bridged With the HeartWare Left Ventricular Assist Device

43. Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure

44. More Frequent Hospitalizations and Worse Quality of Life with Late Right Heart Failure Compared to Early Right Heart Failure after Left Ventricular Assist as Destination Therapy

45. Increased Cell Free DNA Levels in African American Patients Early after Heart Transplantation

46. Long Term Outcomes of African-American LVAD Recipients

47. One-Year Survival Rate after Thoracotomy for Left Ventricular Assist Device Implantation Compared with Sternotomy

48. Comparison of Repeat Exchange Rate after Axial-Flow to Centrifugal-Flow Left Ventricular Assist Device Exchange versus Axial-Flow to Axial-Flow Device Exchange

49. Argatroban as an Alternative Anticoagulant in Impella Supported Patients

50. Cardiac Allograft Injury in Patients of African Ancestry: Trends of Donor-Derived Cell-Free DNA Based on Genetic Ancestry